Free Trial
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel Free PALI Stock Alerts

Palisade Bio (PALI) Short Interest Ratio & Short Volume

Palisade Bio logo
$1.70 -0.02 (-0.88%)
As of 12:15 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Palisade Bio Short Interest Overview

As of May 29, 2026, Palisade Bio (PALI) had a short interest of 30.81 million shares sold short, representing 17.76% of the public float. This marks a 14.44% increase in short interest since the prior report. The short interest ratio (days to cover) is 10.8, meaning it would take 10.8 days of the average trading volume of 3.94 million shares to cover all short positions.

Current Short Interest
30,806,978 shares
Previous Short Interest
26,920,839 shares
Change Vs. Previous Month
14.44%
Dollar Volume Sold Short
$65.31 million
Short Interest Ratio
10.8 Days to Cover
Last Record Date
May 29, 2026
Outstanding Shares
173,580,000 shares
Short Percent of Float
17.76%
Today's Trading Volume
835,922 shares
Average Trading Volume
3,939,508 shares
Today's Volume Vs. Average
21%
Short Selling Palisade Bio?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Palisade Bio and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

PALI Short Interest Over Time

PALI Days to Cover Over Time

PALI Percentage of Float Shorted Over Time

Palisade Bio Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/29/202630,806,978 shares $65.31 million +14.4%17.8%10.79 $2.12
5/15/202626,920,839 shares $49.27 million +3.0%15.5%10.41 $1.83
4/30/202626,147,446 shares $52.29 million +2.0%15.6%5.21 $2.00
4/15/202625,639,730 shares $60.00 million -0.5%15.3%6.97 $2.34
3/31/202625,770,313 shares $45.10 million -1.5%15.5%5.43 $1.75
3/13/202626,152,010 shares $50.73 million -2.2%17.6%8.79 $1.94
2/27/202626,733,844 shares $47.32 million +5.5%18.0%8.83 $1.77
2/13/202625,352,984 shares $43.86 million +20.2%17.0%8 $1.73
1/30/202621,095,322 shares $31.43 million +20.6%14.2%3.5 $1.49
1/15/202617,496,604 shares $30.62 million +9.7%11.7%3.02 $1.75
12/31/202515,949,282 shares $37.48 million +24.4%10.7%2.83 $2.35
12/15/202512,819,308 shares $23.20 million -8.3%8.6%2.24 $1.81
11/28/202513,976,371 shares $29.42 million +75.9%9.4%3.8 $2.11
11/14/20257,946,168 shares $17.00 million +4.6%5.3%2.15 $2.14
10/31/20257,594,147 shares $15.72 million +28.3%5.7%1.53 $2.07
10/15/20255,920,000 shares $10.24 million +469.2%4.8%0.8 $1.73
9/30/20251,040,000 shares $894.09 thousand +109.2%0.9%0.1 $0.86
9/15/2025497,200 shares $294.34 thousand +48.4%5.5%0.2 $0.59
8/31/2025335,100 shares $226.46 thousand -21.0%3.7%0.2 $0.68
8/15/2025424,400 shares $339.94 thousand +26.4%4.7%0.2 $0.80
7/31/2025335,800 shares $342.52 thousand -58.7%7.1%0.2 $1.02
7/15/2025813,900 shares $610.43 thousand -14.3%17.1%1.5 $0.75
6/30/2025949,100 shares $645.48 thousand -15.3%19.9%3.3 $0.68
6/15/20251,120,000 shares $716.91 thousand +391.2%23.5%3.9 $0.64
5/31/2025228,000 shares $166.12 thousand +30.2%4.8%0.5 $0.73
5/15/2025175,100 shares $119.09 thousand +328.1%3.7%0.5 $0.68
4/30/202540,900 shares $31.74 thousand -23.1%0.9%0.1 $0.78
4/15/202553,200 shares $35.89 thousand -69.8%1.2%0.2 $0.67
3/31/2025176,400 shares $120.09 thousand -39.5%4.1%0.3 $0.68
3/15/2025291,500 shares $291.50 thousand +97.0%10.6%0.5 $1.00
2/28/2025148,000 shares $122.69 thousand +38.5%5.4%0.1 $0.83
2/15/2025106,900 shares $111.18 thousand -22.0%3.9%0.1 $1.04
1/31/2025137,000 shares $186.32 thousand +176.8%5.0%0.1 $1.36
1/15/202549,500 shares $87.12 thousand -25.3%1.8%0 $1.76
12/31/202466,300 shares $109.40 thousand -96.4%2.4%0.1 $1.65
12/15/20241,840,000 shares $3.26 million +1,610.0%67.7%1.5 $1.77
11/30/2024107,600 shares $264.70 thousand -6.2%7.7%1.1 $2.46
11/15/2024114,700 shares $289.04 thousand +166.1%8.8%1.4 $2.52
10/31/202443,100 shares $117.23 thousand +158.1%3.3%0.6 $2.72
10/15/202416,700 shares $59.29 thousand -30.1%1.4%0.3 $3.55
Read this warning immediately (Ad)

Porter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776. One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift.tc pixel

Read Porter Stansberry's full breakdown and protect your wealth now
9/30/202423,900 shares $84.85 thousand -57.4%2.1%0.4 $3.55
9/15/202456,100 shares $212.62 thousand +13.3%4.8%0.9 $3.79
8/31/202449,500 shares $174.74 thousand -17.8%4.3%0.8 $3.53
8/15/202460,200 shares $223.34 thousand -46.2%5.2%0.9 $3.71
7/31/2024111,900 shares $438.65 thousand +105.0%12.2%1.6 $3.92
7/15/202454,600 shares $234.78 thousand +129.4%6.0%0.1 $4.30
6/30/202423,800 shares $107.10 thousand -12.2%2.6%0 $4.50
6/15/202427,100 shares $125.74 thousand -10.0%3.0%0 $4.64
5/31/202430,100 shares $145.08 thousand -14.5%3.3%0 $4.82
5/15/202435,200 shares $224.58 thousand -80.3%3.8%0 $6.38
4/30/2024178,500 shares $1.08 million +417.4%21.3%0.2 $6.03
4/15/202434,500 shares $143.52 thousand +1,816.7%4.1%0 $4.16
3/31/20241,800 shares $10.78 thousand -96.0%N/A0 $5.99
3/15/202445,200 shares $16.29 thousand -41.2%0.5%0 $0.36
2/29/202476,800 shares $30.87 thousand -23.9%0.9%0 $0.40
2/15/2024100,900 shares $44.58 thousand -95.0%1.1%0 $0.44
1/31/20242,000,000 shares $1.20 million +1,450.4%25.7%0.8 $0.60
1/15/2024129,000 shares $67.47 thousand +1,915.6%1.5%0.7 $0.52
12/31/20236,400 shares $3.78 thousand -76.0%0.1%0 $0.59
12/15/202326,700 shares $15.27 thousand -23.5%0.3%0.2 $0.57
11/30/202334,900 shares $21.81 thousand -47.6%0.4%0.2 $0.63
11/15/202366,600 shares $35.30 thousand -52.2%0.8%0 $0.53
10/31/2023139,200 shares $77.26 thousand -35.3%1.7%0 $0.56
10/15/2023215,100 shares $118.89 thousand -7.9%2.6%0.1 $0.55
9/30/2023233,500 shares $135.90 thousand -23.1%2.9%0.1 $0.58
9/15/2023303,600 shares $185.89 thousand +74.9%3.7%0.1 $0.61
8/31/2023173,600 shares $118.36 thousand +14.1%2.6%0.1 $0.68
8/15/2023152,200 shares $96.42 thousand -27.6%2.3%0.4 $0.63
7/31/2023210,100 shares $474.83 thousand -1.2%3.2%0.5 $2.26
7/15/2023212,700 shares $414.77 thousand +342.2%3.2%0.6 $1.95
6/30/202348,100 shares $81.77 thousand -75.2%0.7%0.1 $1.70
6/15/2023194,100 shares $312.50 thousand -25.8%3.0%0.1 $1.61
5/31/2023261,700 shares $345.44 thousand +128.4%4.0%0.2 $1.32
5/15/2023114,600 shares $182.21 thousand -65.0%1.8%0.1 $1.59
4/30/2023327,300 shares $520.41 thousand +4.7%9.8%0.2 $1.59
4/15/2023312,600 shares $593.94 thousand +195.7%10.2%0.2 $1.90
3/31/2023105,700 shares $372.06 thousand -30.7%3.8%0.1 $3.52
3/15/2023152,600 shares $302.15 thousand -33.6%6.5%0.1 $1.98
2/28/2023229,700 shares $496.15 thousand +23.5%11.1%0.1 $2.16
2/15/2023186,000 shares $444.54 thousand +41.8%4.8%0.1 $2.39
1/31/2023131,200 shares $380.48 thousand -38.1%3.5%0 $2.90
1/15/2023211,800 shares $565.51 thousand +176.9%9.0%0.1 $2.67
12/30/202276,500 shares $397.80 thousand -21.9%3.2%0 $5.20
12/15/202297,900 shares $224.19 thousand -77.1%7.2%0.1 $2.29
11/30/2022428,000 shares $1.66 million +14,166.7%31.7%0.3 $3.89
11/15/20223,000 shares $200.10 -98.5%0.2%0 $0.07
10/31/2022204,500 shares $18.63 thousand +11.4%0.3%0 $0.09
10/15/2022183,600 shares $17.42 thousand -37.9%0.3%0 $0.09
9/30/2022295,400 shares $29.24 thousand -68.9%0.5%0.1 $0.10
9/15/2022949,200 shares $142.38 thousand +3.4%2.0%0.2 $0.15
SpaceX will crumble without these 5 companies (Ad)

The SpaceX IPO is drawing near, but the real opportunity may lie in 5 lesser-known companies providing the critical infrastructure SpaceX depends on to operate. Goldman Sachs and Morgan Stanley are reportedly already building positions in one of these names. Another is a resource miner that Elon Musk's broader empire - including Tesla - relies on. Lance Ippolito has detailed all five inside his free SpaceX Investing Blackbook.tc pixel

Download the free SpaceX Investing Blackbook before these names go mainstream
8/31/2022918,300 shares $149.50 thousand -58.6%6.4%0.3 $0.16
8/15/20222,220,000 shares $517.26 thousand +213.6%11.4%1 $0.23
7/31/2022707,900 shares $273.53 thousand +42.8%3.0%2.9 $0.39
7/15/2022495,700 shares $232.98 thousand +8.8%2.1%2.2 $0.47
6/30/2022455,800 shares $185.97 thousand +4.8%2.0%1.9 $0.41
6/15/2022435,000 shares $208.15 thousand -0.7%2.2%1.3 $0.48
5/31/2022438,100 shares $229.13 thousand -9.1%2.2%0.3 $0.52
5/15/2022481,800 shares $243.55 thousand -59.5%2.5%0.3 $0.51
4/30/20221,190,000 shares $928.20 thousand +0.9%7.4%0.7 $0.78
4/15/20221,180,000 shares $1.10 million -10.6%7.3%0.6 $0.93
3/31/20221,320,000 shares $1.40 million +1,101.1%8.4%0.6 $1.06
3/15/2022109,900 shares $129.68 thousand +67.5%0.9%0.1 $1.18
2/28/202265,600 shares $60.35 thousand -43.7%0.6%0.1 $0.92
2/15/2022116,600 shares $115.45 thousand -34.8%1.0%0.2 $0.99
1/31/2022178,900 shares $214.68 thousand +5.7%1.5%0.2 $1.20
1/15/2022169,200 shares $219.96 thousand +50.8%1.4%0.9 $1.30
12/31/2021112,200 shares $145.86 thousand -23.3%1.0%0.6 $1.30
12/15/2021146,200 shares $279.24 thousand -67.7%1.3%0.5 $1.91
11/30/2021453,000 shares $1.06 million -24.7%3.9%1.3 $2.33
11/15/2021601,900 shares $1.62 million +20.7%5.2%1.4 $2.69
10/29/2021498,800 shares $1.37 million +30.3%4.5%1.2 $2.74
10/15/2021382,900 shares $1.06 million -44.5%3.5%0.7 $2.76
9/30/2021690,300 shares $1.83 million +19.6%6.2%1.2 $2.65
9/15/2021577,400 shares $1.62 million +79.1%5.4%1 $2.80
8/31/2021322,400 shares $905.94 thousand -12.9%3.4%0.6 $2.81
8/13/2021370,000 shares $962 thousand No Change3.3%0.7 $2.60

PALI Short Interest - Frequently Asked Questions

Short interest is the volume of Palisade Bio shares that have been sold short but have not yet been closed out or covered. As of May 29th, traders have sold 30,806,978 shares of PALI short. 17.76% of Palisade Bio's shares are currently sold short. Learn More on Palisade Bio's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PALI shares currently have a short interest ratio of 10.8. Learn More on Palisade Bio's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 17.76% of Palisade Bio's floating shares are currently sold short.

Palisade Bio saw a increase in short interest during the month of May. As of May 29th, there was short interest totaling 30,806,978 shares, an increase of 14.4% from the previous total of 26,920,839 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

17.76% of Palisade Bio's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Palisade Bio: Xeris Biopharma Holdings, Inc. (7.58%), Collegium Pharmaceutical, Inc. (17.79%), WAVE Life Sciences Ltd. (12.72%), Schrodinger, Inc. (15.71%), Cronos Group Inc. (1.03%), Aktis Oncology (4.99%), Savara Inc. (15.56%), Evotec AG (0.02%), DBV Technologies S.A. (2.85%), Corvus Pharmaceuticals, Inc. (25.66%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($81.27 billion), Invesco QQQ ($49.06 billion), iShares Russell 2000 ETF ($23.61 billion), Western Digital Corporation ($16.93 billion), Sandisk Corporation ($15.61 billion), Salesforce Inc. ($11.65 billion), SPDR S&P Biotech ETF ($10.52 billion), Nebius Group N.V. ($10.24 billion), Lumentum Holdings Inc. ($8.74 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($8.21 billion). View all of the most shorted stocks.

Short selling PALI is an investing strategy that aims to generate trading profit from Palisade Bio as its price is falling. PALI shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Palisade Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PALI, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PALI, twice per month. The most recent reporting period available is May, 29 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like PALI:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:PALI) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel